Kaleido Biosciences, Inc.
KLDODelisted Apr 18, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001751299
Kaleido Biosciences, Inc. was delisted on Apr 18, 2022; its insiders filed their last Form 4 on Mar 2, 2022; 63 institutions reported holding it in 13F filings for Q1 2022, worth $55.1M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 63
- Q1 2022, −2 vs. previous quarter
- 13F value
- $55.1M
- Reported value at the end of Q1 2022
- Superinvestors holding
- 0
- At the end of Q1 2022
Superinvestors holding KLDO, Q1 2022
No superinvestor reported holding KLDO at the end of Q1 2022.
Latest insider trades
Open-market purchases and sales by Kaleido Biosciences, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Kaleido Biosciences, Inc. insiders are on file.
Top 10 13F holders, Q1 2022
The largest institutional positions in Kaleido Biosciences, Inc. at the end of Q1 2022; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 19,575,710 | $32.3M | 0.76% | 00.0% | Unchanged |
| FMR LLC | 6,389,660 | $10.5M | 0.00% | +5080.0% | Added |
| HarbourVest Partners LLC | 1,833,832 | $3.03M | 0.62% | 00.0% | Unchanged |
| BlackRock Inc. | 913,506 | $1.51M | 0.00% | −10,325−1.1% | Reduced |
| Vanguard Group Inc | 870,602 | $1.44M | 0.00% | −166,785−16.1% | Reduced |
| Baillie Gifford & Co | 733,525 | $1.21M | 0.00% | +12,013+1.7% | Added |
| Federated Hermes, Inc. | 607,687 | $1.00M | 0.00% | +1,484+0.2% | Added |
| Artal Group S.A. | 500,500 | $826.0K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 435,024 | $718.0K | 0.00% | +5,037+1.2% | Added |
| Geode Capital Management, LLC | 336,879 | $555.0K | 0.00% | −1,541−0.5% | Reduced |